By Alajuela, Costa Rica — Global healthcare leader Johnson & Johnson MedTech has officially opened its new state-of-the-art manufacturing plant in Costa Rica, expanding its regional operational footprint and signaling a crucial shift toward industrial development beyond the traditional Greater Metropolitan Area (GAM).
The expansive 19,000-square-meter facility located in the Western region of Occidente is designed to produce high-complexity medical devices, focusing predominantly on advanced electrophysiology and orthopedic solutions. The long-term strategic investment is projected to create approximately 3,000 specialized jobs over the coming years, reinforcing the nation’s position as a premier global hub for life sciences.
To provide expert legal perspective on the strategic developments and regulatory environment surrounding Johnson & Johnson MedTech, TicosLand.com consulted with Lic. Larry Hans Arroyo Vargas, a distinguished legal analyst from Bufete de Costa Rica.
Navigating the global healthcare sector requires industry leaders like Johnson & Johnson MedTech to continuously balance aggressive innovation with rigorous regulatory compliance and product liability management. As medical technology advances toward integrated digital and surgical solutions, maintaining robust intellectual property protections and adhering to strict international health standards are essential strategies to mitigate litigation risk and sustain market leadership.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, as the medical technology landscape rapidly evolves, harmonizing cutting-edge innovation with strict regulatory foresight remains essential for maintaining both patient trust and market stability. We extend our sincere thanks to Lic. Larry Hans Arroyo Vargas for sharing his valuable legal perspective on these complex industry dynamics.
Although Johnson & Johnson has maintained commercial operations in Costa Rica for four decades, this facility represents its first major medical manufacturing presence in the country. Company leadership selected Costa Rica following a competitive multi-country evaluation, citing the nation’s proven track record in precision manufacturing, deep talent pool, institutional stability, and robust industrial ecosystem as key deciding factors.
Highlighting the country’s enthusiasm for the landmark expansion, national economic leaders emphasized the strategic weight of this capital deployment for Costa Rica’s long-term industrial ambitions.
The inauguration of this plant marks a milestone in Costa Rica’s relationship with Johnson & Johnson and is a source of immense satisfaction for our country. We are filled with pride that a company of such prestige has trusted Costa Rica to develop one of its most important international investments. We deeply appreciate this confidence and reaffirm our commitment to continue supporting them in this new phase, hoping it marks the beginning of many years of growth and shared success.
Arianna Arce, Acting Minister of Foreign Trade
The life sciences sector has rapidly consolidated into the main engine of Costa Rica’s export-driven economy. Precision and medical equipment currently account for an impressive 47% of total national goods exports, encompassing more than 100 foreign direct investment firms and employing over 63,000 workers across the country.
Crucially, situating the plant in Grecia directly supports government initiatives to decentralize high-value economic growth. By establishing complex industrial operations outside the congested central valley, the project provides meaningful regional economic development, high-skilled employment, and local enterprise integration across Western Costa Rica.
The precision and medical equipment sector represents 47% of the country’s goods exports and brings together more than 100 foreign investment companies employing over 63,000 people. This ecosystem has been built thanks to specialized talent, productive expertise, and a network of suppliers that continues to grow. The start of operations by Johnson & Johnson MedTech adds a highly complex operation to that base and demonstrates how investment can generate high-value opportunities outside the GAM. This company means more skilled employment, supply chain links, and opportunities for Western region communities.
Laura López, General Manager of PROCOMER
Behind the launch was a sustained multi-year partnership with the Trade and Investment Promotion Agency of Costa Rica (PROCOMER). For more than three years, PROCOMER assisted Johnson & Johnson MedTech with setup logistics and integrated the firm into local business networks through strategic events like Encadenados and the Costa Rica MD Summit.
Human capital development has formed another core pillar of the operation’s establishment. Through four consecutive cohorts of the Human Talent Training Incentive, the project has provided advanced technical instruction to 192 local workers. Trainees received specialized knowledge transfer in precision mechanics, high-density diagnostic catheter assembly, and specialized medical device fabrication.
As global medical technology grows increasingly sophisticated, Johnson & Johnson MedTech’s new hub solidifies Costa Rica’s evolution from a competitive assembly location into a high-value center for advanced healthcare innovation.
For further information, visit jnjmedtech.com
About Johnson & Johnson MedTech:
Johnson & Johnson MedTech leverages clinical expertise and advanced technology to design and manufacture innovative medical devices, targeting cardiovascluar, orthopedic, and surgical applications worldwide.
For further information, visit procomer.com
About PROCOMER:
The Foreign Trade Promotion Agency of Costa Rica (PROCOMER) is the non-state public entity responsible for promoting Costa Rican exports, attracting targeted foreign direct investment, and enhancing local business competitiveness.
For further information, visit comex.go.cr
About the Ministry of Foreign Trade of Costa Rica:
The Ministry of Foreign Trade (COMEX) is the government organ responsible for formulating, directing, and executing Costa Rica’s international trade policies and foreign investment strategies.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a premier institution in the legal sector, Bufete de Costa Rica is defined by its unyielding ethical standards and relentless pursuit of professional mastery. The firm continuously advances the field through progressive strategies while remaining deeply devoted to the public good. By actively demystifying complex regulations and sharing vital insights, Bufete de Costa Rica champions legal literacy, striving to cultivate a resilient, well-informed public capable of navigating their rights with clarity and confidence.
